Current Outpatient Cardiac Rehabilitation in Austria

April 22, 2022 updated by: Prof. Josef Niebauer M.D., Ph.D., MBA, Paracelsus Medical University

Outpatient Cardiac Rehabilitation in Austria

Aim of this study is to give evidence to outpatient cardiac rehabilitation in Austria. The database created in this context is supposed to pave the way as instrument to document and comprehend quality of outpatient cardiac rehabilitation in Austria as a key for quality management. Analyses of the created database should be made on a regular basis.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

8000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Austria
      • Salzburg, Austria, 5020
        • Institute of Sports Medicine, Prevention and Rehabilitation, Paracelsus Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 99 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who qualified for an outpatient cardiac rehabilitation

Description

Inclusion Criteria:

Any patient who meets inclusion criteria for outpatient cardiac rehabilitation in Austria -

Exclusion Criteria:

  • Medical conditions which prevent patients from complying with the exercise program
  • Acute infections
  • Hypertrophic cardiomyopathy
  • Pulmonary artery embolism or phlebothrombosis within the previous 6 months
  • Unstable angina pectoris
  • Heart failure (NYHA IV)
  • Hemodynamically unstable arrhythmia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Physical Work Capacity (PWC) in Phase II rehabilitation
Time Frame: 6 weeks
PWC is measured by a graded exercise test on a cycle ergometer at start and end of outpatient cardiac rehabilitation
6 weeks
Change from baseline in Physical Work Capacity (PWC) in Phase III rehabilitation
Time Frame: 1 year
PWC is measured by a graded exercise test on a cycle ergometer at start and end of outpatient cardiac rehabilitation
1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline in Cholesterol in Phase II rehabilitation
Time Frame: 6 weeks
Venous blood samples are taken to assess Cholesterol
6 weeks
Change from baseline in Cholesterol in Phase III rehabilitation
Time Frame: 1 year
Venous blood samples are taken to assess Cholesterol
1 year
Change from baseline in Triglycerides in Phase II rehabilitation
Time Frame: 6 weeks
Venous blood samples are taken to assess Triglycerides
6 weeks
Change from baseline in Triglycerides in Phase III rehabilitation
Time Frame: 1 year
Venous blood samples are taken to assess Triglycerides
1 year
Change from baseline in Blood Glucose in Phase II rehabilitation
Time Frame: 6 weeks
Venous blood samples are taken to assess blood glucose
6 weeks
Change from baseline in Blood Glucose in Phase III rehabilitation
Time Frame: 1 year
Venous blood samples are taken to assess blood glucose
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Paracelsus Medical University

Investigators

  • Study Chair: Prof. Josef Niebauer, MD, PhD, MBA, Institute of Sports Medicine, Prevention and Rehabilitation Paracelsus Medical University Salzburg, Austria

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2005

Primary Completion (Actual)

December 1, 2018

Study Completion (Actual)

December 1, 2021

Study Registration Dates

First Submitted

October 17, 2017

First Submitted That Met QC Criteria

March 6, 2018

First Posted (Actual)

March 13, 2018

Study Record Updates

Last Update Posted (Actual)

April 25, 2022

Last Update Submitted That Met QC Criteria

April 22, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UISM-11

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Physical activity

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe